MedPath

Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia

Not Applicable
Recruiting
Conditions
Avoidant/Restrictive Food Intake Disorder
Dyspepsia
Cognitive Behavioral Therapy
Behavioral Medicine
Feeding and Eating Disorders
Functional Dyspepsia
Appetite Regulation
Post-prandial Distress Syndrome
Interventions
Behavioral: Cognitive Behavioral Therapy
Registration Number
NCT05587127
Lead Sponsor
Massachusetts General Hospital
Brief Summary

Randomized controlled trial of an exposure-based behavioral treatment (CBT) in adults with functional dyspepsia who meet criteria for avoidant/restrictive food intake disorder (ARFID) with weight loss.

Detailed Description

The purpose of this study is to conduct a randomized controlled trial (RCT) of a cognitive-behavioral treatment (CBT) compared to usual care as the control with adults with functional dyspepsia who also meet criteria for avoidant/restrictive food intake disorder (ARFID). Participants randomized into the CBT group will receive eight 1-hour sessions delivered weekly via the MGH-approved secure video platform Enterprise Zoom while the usual care group will be allowed to continue with treatment they are already receiving at the time of randomization. Participants in the usual care group will be offered CBT after study participation. We will determine the feasibility and acceptability of the CBT and explore changes in clinical outcomes and preliminary mechanisms.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cognitive Behavioral TherapyCognitive Behavioral TherapySubjects will receive cognitive behavioral therapy for functional dyspepsia with avoidant restrictive food intake disorder.
Primary Outcome Measures
NameTimeMethod
RetentionThroughout study completion, an average of 3 years

At the end of the study, we will calculate the percentage of participants who complete at least 6 of the 8 CBT sessions.

Interventionist Fidelity ratingsThroughout study completion, an average of 3 years

At the end of the study, we will calculate fidelity, which measures the percentage of sessions that 100% of the CBT content was delivered.

EnrollmentThroughout study completion, an average of 3 years

At the end of the study, we will calculate the percentage of participants who consent to initiate the study from the total who are offered.

Assessment completionThroughout study completion, an average of 3 years

At the end of the study, we will calculate the percentage of participants who complete all assessments in each CBT and usual care groups.

Client SatisfactionWeek 12

The Client Satisfaction Questionnaire (CSQ) is an 8 item self-report measure that assesses treatment satisfaction. Higher scores indicate greater treatment satisfaction.

Secondary Outcome Measures
NameTimeMethod
Short Form Nepean Dyspepsia Inventory (SF-NDI)Weeks 0, 6, and 12

The Short Form Nepean Dyspepsia Inventory (SF-NDI) includes a 15 item symptoms checklist to assess functional dyspepsia symptom severity. It also includes 10 items scored on a 5-point Likert scale measuring functional dyspepsia-related quality of life; subscales include interference with daily activities, knowledge/control, tension, work/study, and eating/drinking.

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath